Toshiharu Okugawa

Presentation of a major histocompatibility complex class 1–binding peptide by monocyte-derived dendritic cells incorporating hydrophobized polysaccharide–truncated HER2 protein complex: implications for a polyvalent immuno-cell therapy

Yasushi Ikuta, Naoyuki Katayama, Lijie Wang et al. · Blood · 2002 · 107 citations · Full text

Life Sciences, Cell Biology, Immunology +15

Development of a cancer vaccine: peptides, proteins, and DNA

Hiroshi Shiku, Lijie Wang, Yasushi Ikuta et al. · Cancer Chemotherapy and Pharmacology · 2000 · 51 citations

Medicine, Immunology, Oncology +12

A novel human HER2-derived peptide homologous to the mouse Kd-restricted tumor rejection antigen can induce HLA-A24-restricted cytotoxic T lymphocytes in ovarian cancer patients and healthy individuals

Toshiharu Okugawa, Yasushi Ikuta, Yoshiyuki Takahashi et al. · European Journal of Immunology · 2000 · 49 citations · Full text

Life Sciences, Immunology, Oncology +17

A HER2/NEU-derived peptide, a Kd-restricted murine tumor rejection antigen, induces HER2-specific HLA-A2402-restricted CD8+ cytotoxic T lymphocytes

Yasushi Ikuta, Toshiharu Okugawa, Reiko Furugen et al. · International Journal of Cancer · 2000 · 43 citations · Full text

Life Sciences, Immunology, Oncology +17

Large or persistent lymphocyst increases the risk of lymphedema, lymphangitis, and deep vein thrombosis after retroperitoneal lymphadenectomy for gynecologic malignancy

Eiji Kondo, Tsutomu Tabata, Takaya Shiozaki et al. · Archives of Gynecology and Obstetrics · 2013 · 26 citations

Medicine, Gynecology, Surgery +9